ARCHIVES

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

December 6, 2002

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002